中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/29053
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1995939      Online Users : 499
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > China Medical University Hospital > Jurnal articles >  Item 310903500/29053
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/29053


    Title: Novel clonal der(8)t(8;14)(p11;q11),del(9)(q13q22) and t(14;22) (q13;q13) in a patient with fulminant adult T-cell leukemia/lymphoma
    Authors: Yeh, SP;Yu, MT;Chow, KC;Lai, LY;Chiu, CF
    Contributors: 附設醫院內科部血液腫瘤科;China Med Coll Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Canc Res Ctr, Stem Cell Res Lab, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Cytogenet Lab, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Canc Res Ctr, Taichung 404, Taiwan
    Date: 2002
    Issue Date: 2010-09-24 14:20:00 (UTC+8)
    Publisher: ELSEVIER SCIENCE INC
    Abstract: Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative rate rather than tumor burden. The purpose of this study was to assess the clinical value of TPS in patients with renal cell carcinoma (RCC). Serum levels of TPS were measured in 30 patients with locoregional and in 20 patients with advanced disease before and after therapy. The results showed that: (1) the detection sensitivity of TPS for RCC is 60.0%; (2) the detection sensitivity of TPS in advanced RCC (100.0%) was significantly higher than in locoregional RCC (33.3%); (3) the 10 locoregional RCC patients without recurrence had normal serum TPS levels during a follow-up period of 1 year; and (4) the 8 advanced RCC patients with good response during therapy had normal serum TPS levels, while 12 patients with poor disease had significantly elevated serum TPS levels during a follow-up period of 1 year. Our results suggest that TPS may have a potential clinical role as a valuable tumor marker for RCC, especially in advanced diseases and follow-up therapy response.
    Relation: CANCER GENETICS AND CYTOGENETICS 139(1):34-37
    Appears in Collections:[China Medical University Hospital] Jurnal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback